Follow
Javier Valero-Elizondo, MD, MPH
Javier Valero-Elizondo, MD, MPH
Unknown affiliation
Verified email at amgen.com
Title
Cited by
Cited by
Year
National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey
JA Salami, H Warraich, J Valero-Elizondo, ES Spatz, NR Desai, JS Rana, ...
JAMA cardiology 2 (1), 56-65, 2017
3632017
Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease
Z Javed, M Haisum Maqsood, T Yahya, Z Amin, I Acquah, ...
Circulation: Cardiovascular Quality and Outcomes 15 (1), e007917, 2022
1582022
Trends in differences in health status and health care access and affordability by race and ethnicity in the United States, 1999-2018
S Mahajan, C Caraballo, Y Lu, J Valero-Elizondo, D Massey, ...
Jama 326 (7), 637-648, 2021
1482021
Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017
R Khera, J Valero-Elizondo, SR Das, SS Virani, BA Kash, JA De Lemos, ...
Circulation 140 (25), 2067-2075, 2019
1222019
Association of subjective and objective sleep duration as well as sleep quality with non-invasive markers of sub-clinical cardiovascular disease (CVD): a systematic review
M Aziz, SS Ali, S Das, A Younus, R Malik, MA Latif, C Humayun, ...
Journal of atherosclerosis and thrombosis 24 (3), 208-226, 2017
1162017
Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity
MH Jilani, Z Javed, T Yahya, J Valero-Elizondo, SU Khan, B Kash, ...
Current atherosclerosis reports 23, 1-11, 2021
982021
Gender differences in patient‐reported outcomes among adults with atherosclerotic cardiovascular disease
V Okunrintemi, J Valero‐Elizondo, B Patrick, J Salami, M Tibuakuu, ...
Journal of the American Heart Association 7 (24), e010498, 2018
952018
Patient–provider communication and health outcomes among individuals with atherosclerotic cardiovascular disease in the United States: Medical Expenditure Panel Survey 2010 to 2013
V Okunrintemi, ES Spatz, P Di Capua, JA Salami, J Valero-Elizondo, ...
Circulation: Cardiovascular Quality and Outcomes 10 (4), e003635, 2017
882017
Association of out-of-pocket annual health expenditures with financial hardship in low-income adults with atherosclerotic cardiovascular disease in the United States
R Khera, J Valero-Elizondo, V Okunrintemi, A Saxena, SR Das, ...
JAMA cardiology 3 (8), 729-738, 2018
862018
Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions
R Khera, J Valero-Elizondo, K Nasir
Journal of the American Heart Association 9 (19), e017793, 2020
812020
Financial hardship from medical bills among nonelderly US adults with atherosclerotic cardiovascular disease
J Valero-Elizondo, R Khera, A Saxena, GR Grandhi, SS Virani, J Butler, ...
Journal of the American College of Cardiology 73 (6), 727-732, 2019
652019
Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States
C Caraballo, J Valero-Elizondo, R Khera, S Mahajan, GR Grandhi, ...
Circulation: Cardiovascular Quality and Outcomes 13 (2), e006139, 2020
602020
Economic impact of moderate‐vigorous physical activity among those with and without established cardiovascular disease: 2012 Medical Expenditure Panel Survey
J Valero‐Elizondo, JA Salami, CU Osondu, O Ogunmoroti, A Arrieta, ...
Journal of the American Heart Association 5 (9), e003614, 2016
592016
Association of income disparities with patient-reported healthcare experience
V Okunrintemi, R Khera, ES Spatz, JA Salami, J Valero-Elizondo, ...
Journal of general internal medicine 34, 884-892, 2019
572019
Variation and disparities in awareness of myocardial infarction symptoms among adults in the United States
S Mahajan, J Valero-Elizondo, R Khera, NR Desai, R Blankstein, ...
JAMA network open 2 (12), e1917885-e1917885, 2019
552019
Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta‐analysis
EC Aneni, A Crippa, CU Osondu, J Valero‐Elizondo, A Younus, K Nasir, ...
Journal of the American Heart Association 6 (12), e006904, 2017
542017
Social determinants of health and obesity: Findings from a national study of US adults
Z Javed, J Valero‐Elizondo, MH Maqsood, S Mahajan, MB Taha, KV Patel, ...
Obesity 30 (2), 491-502, 2022
502022
Favorable cardiovascular risk profile is associated with lower healthcare costs and resource utilization: the 2012 Medical Expenditure Panel Survey
J Valero-Elizondo, JA Salami, O Ogunmoroti, CU Osondu, EC Aneni, ...
Circulation: Cardiovascular Quality and Outcomes 9 (2), 143-153, 2016
482016
Out‐of‐pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States
SY Wang, J Valero‐Elizondo, HJ Ali, A Pandey, M Cainzos‐Achirica, ...
Journal of the American Heart Association 10 (14), e022164, 2021
452021
Absence of coronary artery calcification in middle-aged familial hypercholesterolemia patients without atherosclerotic cardiovascular disease
R Mszar, GR Grandhi, J Valero-Elizondo, SS Virani, R Blankstein, ...
Cardiovascular Imaging 13 (4), 1090-1092, 2020
422020
The system can't perform the operation now. Try again later.
Articles 1–20